Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 4.4 Billion | USD 6.8 Billion | 6.4% | 2021 |
FrequentlyAsked Questions
The global pleural effusions treatment market growth may be propelled by the rising number of medical cases pertaining to congestive heart failure, pneumonia, lung cancer, and tuberculosis.
According to Zion Market Research, the pleural effusions treatment market size was worth around USD 4.4 billion in 2021 and is predicted to grow to around USD 6.8 billion by 2028 with a compound annual growth rate (CAGR) of roughly 6.4% between 2022 and 2028
The global pleural effusion treatment market cap is expected to be dominated by North America in the coming years owing to the large-scale investment in the pharmaceutical sector along with the presence of excellent medical reimbursement policies and advanced healthcare infrastructure.
The global pleural effusion treatment market is dominated by players like TruCorp, B. Braun Melsungen AG, Cook, Rocket Medical plc, Yushin Medical Co ltd, Boston Medical Products Inc. (Bess group company), Cardinal Health, Smiths Medical, and Armstrong Medical.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed